
After Crozer closure, confusion lingers amid wait for auction of Prospect Medical Holdings' medical campuses
CBS News Philadelphia has been tracking the effects, as well as following bankruptcy auctions of other medical campuses still operating under California-based Prospect Medical Holdings.
The details of an auction that was scheduled for Tuesday have not been revealed. One health system involved in the bidding process is expected to issue a news release at some point Wednesday, sources say.
Cloud of confusion hangs in air after Crozer Health closure
There are small, isolated parts of the Crozer Health system that survived the widespread closures because they're independently owned businesses operating out of buildings not owned by Prospect Medical Holdings. But a cloud of confusion hangs in the air.
"I love all of ya. But I love him the best," Viola Kilson said, surrounded by a group of doctors.
Make no mistake, Kilson is grateful some of her doctors are still in practice. At 104 years old, she was among Crozer Health's most senior patients. She was blunt in her assessment of the system's collapse and financial ruin.
"Catastrophe," she said. "I've been here since my family came from South Carolina in 1931."
Earlier this month, CBS News Philadelphia met with Kilson at her ophthalmologist's office. They're still open in a post-Crozer world. That's because the building, adjacent to the shuttered Crozer Chester Medical Center, is not owned by its parent company, Prospect Medical Holdings.
The doctors, who were formerly affiliated with Crozer, are independent of any system.
Prospect Medical Holdings, the bankrupt private equity firm, closed two hospitals and scores of other medical offices last month.
"Our building is adjacent to Crozer, but it is completely independent," Dr. John Witherell, an ophthalmologist, said. "We're able to function without Crozer. We will continue to function without Crozer."
Witherell and Dr. Christopher Williams say the last few weeks have been terribly confusing. Their staff ramped up what feels like its own marketing agency, alerting patients they're still open, despite living in the shadow of a closed medical center.
"To hear every fourth patient ask, 'Are you closing, are you shutting down, are you leaving us?' That's heartbreaking," Williams said.
Other doctors, part of a cardiology practice, say people also assumed they were included in the widespread closures. They say their practice in Upland and Chester is vital.
"A lot of our patients, this is walking distance, walking distance," Dr. John Godfrey of Cardiology Consultants of Philadelphia said.
A month later, impacts of Crozer closure still felt in Delco
CBS News Philadelphia has been investigating the impact of the Crozer Health shutdown. Former Crozer patients have told us they've spent hours trying to find new doctors. Some can't get appointments until next year.
Kilson has yet to set up a new doctor.
"It's really tough," she said. "I feel for the people younger than me. You just have to get on the phone, and my insurance was nice enough to send me two names."
These doctors say there was no roadmap on how to manage what has become a medical crisis in Delaware County.
"Today, to see the doors closed to the hospital and employees laid off, it's devastating emotionally and psychologically that this could all disappear," Williams said.
"Just the overall disappointment as to where we were and where we are now and how it came to be that way," Witherell said. "I think it's sad. An entire health care system could implode."
But these medical professionals are staying behind, and that's some comfort to Viola Kilson, who is heartbroken about what happened to Crozer.
"Crozer is like home," she said. "It feels like home. And you're losing your home when you lose Crozer Hospital."
Other Prospect facilities still open, such as medical centers in Glen Mills, Haverford and Broomall, are part of an auction process. These facilities were separated from the closure process because they were deemed viable, according to sources, who claim they are profitable.
Prospect attorneys and a spokesperson did not respond to repeated requests for comment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Oracle Corporation (ORCL) Launches Globally Distributed Exadata Database on Exascale Infrastructure
With strong share price gains and significant hedge fund interest, Oracle Corporation (NYSE:ORCL) secures a spot on our list of the 11 Hot Software Stocks to Buy Now. Ken Wolter/ On August 8, 2025, Oracle Corporation (NYSE:ORCL) was recognized as a Leader in Gartner's Magic Quadrant for Strategic Cloud Platform Services for the third consecutive year. This highlights increasing global demand for the company's AI infrastructure and distributed cloud capabilities. On the previous day, Oracle Corporation (NYSE:ORCL) launched its Globally Distributed Exadata Database on Exascale Infrastructure. With this launch, the company enables mission-critical applications to operate seamlessly across OCI regions globally. It offers always-on availability, petabyte-scale AI processing, and flexible serverless scaling. Meanwhile, on August 6, 2025, Oracle Corporation (NYSE:ORCL)'s Oracle Financial Services achieved top honors from Celent across six digital banking evaluations. The recognition includes 'Luminary' status in Corporate Digital Banking Reports and XCelent Awards for 'Breadth of Functionality' in retail and SMB banking platforms. Thus, Oracle Corporation (NYSE:ORCL) is strengthening its leadership across AI, cloud, data management, and financial services technology with these achievements. Oracle Corporation (NYSE:ORCL) offers integrated cloud applications and secure, autonomous infrastructure. It helps businesses run workloads efficiently. It is included in our list of the hot stocks to buy. While we acknowledge the potential of ORCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Sign in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
RBC Capital Raises PT on Mastercard Incorporated (MA) to $656; Maintains ‘Outperform' Rating
With a significant presence in Warren Buffett's portfolio and strong hedge fund interest, Mastercard Incorporated (NYSE:MA) secures a spot on our list of the 14 Best Warren Buffett Stocks to Invest in. Valeri Potapova / On August 1, 2025, RBC Capital raised its price target on Mastercard Incorporated (NYSE:MA) from $650 to $656, maintaining an 'Outperform' rating. The price revision follows the company's better-than-expected quarterly results. The quarterly results were also marked by guidance increase for the full year. The analyst believes Mastercard Incorporated (NYSE:MA)'s business trends remained stable through the quarter and into July. Accordingly, consumer spending is expected to remain resilient for the rest of the year. Thus, RBC Capital expects upside potential as the company's growth drivers remain intact and execution remains strong. Operating in the U.S. and the rest of the world, Mastercard Incorporated (NYSE:MA) offers transaction processing and other payment-related products and services. It is included in our list of the best Warren Buffett stocks. While we acknowledge the potential of MA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None.
Yahoo
10 minutes ago
- Yahoo
Barclays Raises PT on Microsoft Corporation (MSFT) to $625; Maintains ‘Overweight' Rating
With strong share price gains and significant hedge fund interest, Microsoft Corporation (NASDAQ:MSFT) secures a spot on our list of the 11 Hot Software Stocks to Buy Now. drserg / On July 31, 2025, Barclays raised its price target on Microsoft Corporation (NASDAQ:MSFT) from $550 to $625, maintaining an 'Overweight' rating. This price revision follows the company's strong Q4 FY25 results. Microsoft Corporation (NASDAQ:MSFT) recorded a 3.5% revenue beat and a 7% operating profit beat, resulting in a 180-basis-point margin growth. Furthermore, over the past year, the company posted a 69.07% gross margin and 14.13% revenue growth. Its Azure platform led the charge, growing 39% YoY in constant currency, exceeding both guidance and investor expectations. Furthermore, the investment firm highlighted the company's dominant position in the software market, making it one of the hot stocks to buy. With expectations of continued traditional cloud migrations and the scaling of generative AI, Microsoft Corporation (NASDAQ: MSFT) offers significant upside potential. Known for Windows, Office, and Azure platforms, Microsoft Corporation (NASDAQ:MSFT) develops and markets software, cloud services, hardware, and AI solutions. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data